新一轮“双一流”名单公布,包含多所医学院校!

2022-02-15 央视新闻客户端 央视新闻客户端

新一轮“双一流”建设高校和建设学科名单发布!

经中央全面深化改革委员会第二十三次会议审议通过,《关于深入推进世界一流大学和一流学科建设的若干意见》近日由教育部、财政部、国家发展改革委印发。经国务院批准,双一流建设高校及建设学科名单更新公布,新一轮建设正式启动。其中包含多所医学院校...

新一轮轮双一流建设高校及建设学科名单(医学院校 / 专业部分)

北京协和医学院:生物学、生物医学工程、临床医学、公共卫生与预防医学、药学

北京中医药大学:中医学、中西医结合、中药学

天津医科大学:临床医学

天津中医药大学:中药学

复旦大学:基础医学、临床医学、公共卫生与预防医学、中西医结合、药学

上海交通大学:基础医学、临床医学、口腔医学、药学

上海中医药大学:中医学、中药学

东南大学:生物医学工程

南京医科大学:公共卫生与预防医学

南京中医药大学:中药学

中国药科大学:中药学

浙江大学:基础医学、临床医学、药学

山东大学:临床医学

武汉大学:口腔医学

华中科技大学:基础医学、临床医学、公共卫生与预防医学

中山大学:基础医学、临床医学

暨南大学:药学

广州医科大学:临床医学

广州中医药大学:中医学

四川大学:基础医学、口腔医学、护理学

成都中医药大学:中药学

海军军医大学:基础医学

空军军医大学:临床医学

给予公开警示(含撤销)的首轮建设学科名单(医学院校 / 专业部分)

北京中医药大学:中药学

海军军医大学:基础医学

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-25 ms5000000518166734

    学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-20 ms5000000518166734

    学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-20 ms8000002000106074

    •᷄ࡇ•᷅

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-16 ms3000000734162967

    🌝

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1941050, encodeId=2f851941050b5, content=<a href='/topic/show?id=5bdc342e5e9' target=_blank style='color:#2F92EE;'>#医学院校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34275, encryptionId=5bdc342e5e9, topicName=医学院校)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Fri Jan 13 16:10:48 CST 2023, time=2023-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859894, encodeId=662818598948a, content=<a href='/topic/show?id=f0a6342e2b0' target=_blank style='color:#2F92EE;'>#医学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34272, encryptionId=f0a6342e2b0, topicName=医学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Sep 08 01:10:48 CST 2022, time=2022-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060800, encodeId=4247206080049, content=<a href='/topic/show?id=8a2c3e38122' target=_blank style='color:#2F92EE;'>#双一流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37381, encryptionId=8a2c3e38122, topicName=双一流)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Mon Jan 30 11:10:48 CST 2023, time=2023-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197338, encodeId=78f7119e33832, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Fri Feb 25 23:10:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195449, encodeId=2030119544908, content=学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Sun Feb 20 22:05:13 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195249, encodeId=719a1195249f1, content=•᷄ࡇ•᷅, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83ec5455618, createdName=ms8000002000106074, createdTime=Sun Feb 20 00:07:04 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193928, encodeId=32be119392878, content=🌝, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd96166904, createdName=ms3000000734162967, createdTime=Wed Feb 16 09:55:29 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193693, encodeId=904411936933b, content=👏👏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae3e5710484, createdName=ms8000000908018201, createdTime=Tue Feb 15 18:48:30 CST 2022, time=2022-02-15, status=1, ipAttribution=)]
    2022-02-15 ms8000000908018201

    👏👏

    0

相关资讯

医学院校是时候该探索一条新模式了!

医学教育和一般教育不同。医学教育的特殊性,决定了医学院校不能照搬其他学科的教育模式,高水平医学院校建设任重道远。

四川:医学院校给全科留空间

近日从四川省政府获悉,四川出台《关于改革完善全科医生培养与使用激励机制的实施意见》

代表关注医学院校扩招现象:住培基地不够用了

“回顾近几年医疗卫生事业的发展,在医师队伍建设上我们做出了努力,也取得了成效。”3月8日,在声音·责任2019两会医界代表委员座谈会上,国家卫生健康委医政医管局卫生健康监察专员郭燕红指出,在维护医师权益、构建和谐医患关系方面医师界代表委员积极建言献策,特别是去年,在通过法律解决涉医违法犯罪事件的基础上,国务院颁布实施了《医疗纠纷预防和处理条例》,还有首个医师节的到来,都彰显了这方面的显着进步。另外

人大代表:鼓励医学院校在全国范围内办医院,解决“看病难”

今年全国两会期间,来自山东的全国人大代表孙建博提交了《关于鼓励医学院校在全国范围内办医院的建议》(下称“《建议》”)。《建议》表示,为进一步发挥医学院校的科研技术特长,提高医院的科研医疗水平,应研究出台政策,鼓励医学院校在全国范围内办医院。孙建博提到,随着我国高等教育改革的不断深化,高等医学教育也得到了飞速的发展,医学院校教育规模不断扩大,使得临床教学的师资和教学基地需求和保障日益突出,而医院也面

北京协和医学院率先全面建立医学院校准聘长聘教职制度

近日,北京协和医学院举行首次准聘长聘教职证书颁授仪式。79名教师从校领导手中接过聘书,正式取得准聘长聘教职。学校将通过为其提供优厚待遇和资源配置,引导高端人才潜心向学,重塑教学与研究体系。据悉,此次北京协和医学院在其所有医学学科中开展准聘长聘教职聘任,在我国医学院校中尚属首次。2018年,中共中央国务院印发《关于全面深化新时代教师队伍建设改革的意见》,提出“推行高等学校教师职务聘任制改革,加强聘期

两会|医界代表委员热议:完善医师队伍建设、保障临床用药

医界代表委员热议完善医师队伍建设、保障临床用药、儿童用药安全等话题。